Abstract
Antisense oligodeoxyribonucleotides have been used for decades to achieve sequence-specific silencing of gene expression. However, all early generation oligonucleotides (e.g., those with no other modifications than the phosphorothioate backbone) are inactive in vitro unless administered using a delivery vehicle. These delivery vehicles are usually lipidic but can also be polyamines or some other particulate reagent. We have found that by employing locked nucleic acid (LNA) phosphorothioate gap-mer nucleic acids of 16 mer or less in length, and by carefully controlling the plating conditions of the target cells and duration of the experiment, sequence-specific gene silencing can be achieved at low micromolar concentrations in vitro in the absence of any delivery vehicle. This process of naked oligonucleotide delivery to achieve gene silencing in vivo, which we have termed gymnosis, has been observed in many both adherent and nonadherent cell lines against several different targets genes.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lebedeva, I, Benimetskaya, L, Stein, CA, Vilenchik, M (2000) Delivery of oligonucleotides to cells. Euro J Pharm and Biopharm 50:101–119.
Akhtar, S, Basu, S, Wickstrom, E, Juliano, R (1991) Interactions of antisense DNA oligonucleotide analogs with phospholipid membranes (liposomes). Nucl Acids Res 19:5551–5559.
Stein, CA, Hansen, B, Lai, J, Wu, S, Voskresenskiy, A, Hoeg, A, Worm, J Hedtjarn, M, Souleimanian, N, Miller, P, Soifer, H, Castanotto, D, Benimetskaya, L, Oerum, H, Koch, T (2009) Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides unassisted by transfection reagents. Nucl Acids Res 38:e3.
Fisher, T, Terhorst, T, Cao, X, Wagner, R (1993) Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells. Nucl Acids Res 21:3857–3865.
Moulds, C, Lewis, J, Froehler, B, Grant,D, Huang, T, Milligan, J, Matteuci, M, Wagner, R (1995) Site and mechanism of antisense inhibition of C-5 propyne oligonucleotides. Biochem 34:5044–5053.
Gibbings, DJ, Ciaudo, C, Erhardt, M, and Voinnet, O (2009) Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol 11: 1143–1149.
Lee, YS, Pressman, S, Andress, AP, Kim, K, White, JL, Cassidy, JJ, Li, X, Lubell, K, Lim, do H, Cho, IS, Nakahara, K, Preall, JB, Bellare, P, Sontheimer, EJ, Carthew, RJ (2009) Silencing by small RNAs is linked to endosomal trafficking. Nat Cell Biol 11: 1150–1160.
Straarup, E, Fisker, N, Hedtjarn, M, Lindholm, M, Rosenbohm, C, Aarup, V, Hansen, H, Oerum, H, Hansen, J, Koch, T (2010) Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B expression and improve the lipoprotein profile of mice and non-human primates. Nucl Acids Res 38:7100–7111.
Koch, T, Rosenbohm, C, Hansen, HF, Hansen, B, Straarup, EM, Kauppinen, S (2008) Locked Nucleic Acid: Properties and therapeutic aspects. In: Kurreck, J. (ed) Therapeutic Oligonucleotides. RSC Publishing, Cambridge, p. 103–34.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Soifer, H.S. et al. (2012). Silencing of Gene Expression by Gymnotic Delivery of Antisense Oligonucleotides. In: Kaufmann, M., Klinger, C. (eds) Functional Genomics. Methods in Molecular Biology, vol 815. Springer, New York, NY. https://doi.org/10.1007/978-1-61779-424-7_25
Download citation
DOI: https://doi.org/10.1007/978-1-61779-424-7_25
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-61779-423-0
Online ISBN: 978-1-61779-424-7
eBook Packages: Springer Protocols